Stock Research: Eli Lilly

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Eli Lilly

NYSE:LLY US5324571083
55
  • Value
    18
  • Growth
    92
  • Safety
    Safety
    32
  • Combined
    42
  • Sentiment
    73
  • 360° View
    360° View
    55
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Eli Lilly and Company is a medicine company that discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. It operates in the pharmaceutical industry, with products including Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity, and Zepbound, among others. The company operates globally. In the last fiscal year, the company had a market cap of $731,415 million, profits of $36,624 million, and revenue of $45,043 million with 47,000 employees.

more
Index
Dividends USA
Employee Focus US
Diversity USA
Moonshot Tech
D.J. US Pharmaceutical
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jan-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
18 20 12 27
Growth
92 89 77 19
Safety
Safety
32 39 28 20
Sentiment
73 76 81 34
360° View
360° View
55 55 40 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
72 79 52 31
Opinions Change
52 62 52 48
Pro Holdings
n/a 48 91 45
Market Pulse
46 67 67 62
Sentiment
73 76 81 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
18 20 12 27
Growth
92 89 77 19
Safety Safety
32 39 28 20
Combined
42 43 22 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
9 5 3 16
Price vs. Earnings (P/E)
26 24 9 24
Price vs. Book (P/B)
1 1 1 4
Dividend Yield
81 84 85 86
Value
18 20 12 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
80 67 82 11
Profit Growth
83 90 29 36
Capital Growth
81 54 55 34
Stock Returns
70 69 87 87
Growth
92 89 77 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
19 18 19 13
Refinancing
12 14 17 7
Liquidity
91 61 89 93
Safety Safety
32 39 28 20

Similar Stocks

Discover high‑ranked alternatives to Eli Lilly and broaden your portfolio horizons.

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: